Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study

Publisher： Karger

E-ISSN： 1423-0232|92|1|31-38

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.1, 2016-10, pp. : 31-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paradoxical Reductions in Serum Anti-p53 Autoantibody Levels by Chemotherapy in Unresectable Colorectal Cancer: An Observational Study

By  

Oncology, Vol. 91, Iss. 3, 2016-07 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Relation between Serum Anti-p53 Antibodies and Microvessel Density in Bladder Cancer Patients

By  

Urologia Internationalis, Vol. 73, Iss. 3, 2004-11 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer

By  

International Federation of Gynecology and Obstetrics, Vol. 140, Iss. 2, 2018-02 ,pp. : 247-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-p53 in Breast Cancer: Concordance of Different Assay Procedures and Association with p53 Antigen Expression

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 297-305

Karger

Access to resources Recommend Favorite

Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer

By  

CANCER, Vol. 120, Iss. 20, 2014-10 ,pp. : 3131-3141

John Wiley & Sons Inc

Access to resources Recommend Favorite